Any Anticoagulating Drug in Combination With an Oral NSAID
Identifying Attributes
Care Settings
Country
Publishing Organisation
Type of Quality Indicator
IOM Quality Dimension
Setting-Specific Domain
Defining Attributes
Definition
Number of individuals who are long-term users of anticoagulating drugs with concomitant use of ≥ 1 prescription of NSAID.
Numerator
Number of individuals who are long-term users of anticoagulating drugs acenocoumarol (B01AA07) or warfarin (B01AA03) or phenprocoumon (B01AA04) or dabigatran (B01AE07) or rivaroxaban (B01AF01) or apixaban (B01AF02) or Edoxaban (B01AF03) with concomitant use of ≥ 1 prescription of NSAID (M01A or M01B). Note: individuals who are long-term users of anticoagulating drugs are defined as individuals who use >270 Defined Daily Doses (DDD) of the B01A codes listed
Denominator
Number of individuals who long-term users of ATC-codes acenocoumarol (B01AA07) or warfarin (B01AA03) or phenprocoumon (B01AA04) or dabigatran (B01AE07) or rivaroxaban (B01AF01) or apixaban (B01AF02) or Edoxaban (B01AF03). individuals who are long-term users of anticoagulating drugs are defined as individuals who use >270 Defined Daily Doses (DDD) of the B01A codes listed above. If prescribing database does not report DDD, derive indicator using >270 days of the B01A codes listed above.
Exclusions
Use of Risk Adjustment
Risk Adjustments
Stratifications
Collection and Reporting Attributes
Type of Data Collection
Data Collection Methods
OECD